507 studies found for:    Open Studies | "Anticoagulants"
Show Display Options
Rank Status Study
21 Not yet recruiting Pleotropic Effect of New Oral Anticoagulants
Condition: Atrial Fibrillation
Interventions: Drug: dabigatran;   Drug: ribaroxaban;   Drug: Warfarin
22 Recruiting Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants
Conditions: Venous Thromboembolism;   Atrial Fibrillation
Intervention: Other: complications and compliance with GIHP recommendations
23 Unknown  Reversal of the Antithrombotic Action of New Oral Anticoagulants
Conditions: Thrombosis;   Anticoagulant-induced Bleeding;   Anticoagulant Overdosage;   Hemorrhage
Interventions: Drug: Rivaroxaban;   Drug: Dabigatran
24 Unknown  rFVIIa in ICH in Patients Treated With Anticoagulants or Anti-Platelets
Condition: Intracerebral Hemorrhage
Interventions: Drug: rFVIIa + (vit K in AO patients);   Drug: FFP or aPCC+ vit K in AO treated patients
25 Recruiting Therapy With New Oral Anticoagulants
Conditions: Atrial Fibrillation;   Non-valvular Atrial Fibrillation
Intervention:
26 Unknown  D-Dimer Guided Oral Anticoagulant Treatment (OAT)
Condition: Deep Venous Thrombosis
Interventions: Drug: Phenprocoumon;   Drug: Warfarin-Natrium
27 Recruiting Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion)
Condition: Atrial Fibrillation
Interventions: Drug: Apixaban;   Drug: Parenteral heparin and/or oral Vitamin K antagonist
28 Not yet recruiting Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Conditions: Cancer;   Venous Thromboembolism;   Deep Vein Thrombosis (DVT);   Pulmonary Embolism (PE);   Blood Clot
Interventions: Drug: Rivaroxaban;   Drug: Apixaban;   Drug: Edoxaban;   Drug: Dabigatran;   Drug: Warfarin;   Drug: Dalteparin;   Drug: Enoxaparin;   Drug: Fondaparinux
29 Recruiting Strategy of Continued Versus Interrupted Novel Oral Anti-coagulant at Time of Device Surgery in Patients With Moderate to High Risk of Arterial Thromboembolic Events
Condition: Hematoma
Interventions: Drug: Dabigatran;   Drug: Rivaroxaban;   Drug: Apixaban
30 Recruiting Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists
Conditions: Severe Bleeding;   Urgent Surgery
Intervention:
31 Recruiting Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization Electrode
Condition: Benign Prostatic Hyperplasia
Intervention:
32 Recruiting Epidemiological Study on the Safety of Aspirin in The Health Improvement Network (THIN)
Conditions: Secondary Prevention;   Stroke;   Ischemic Heart Disease;   Coronary Heart Disease
Interventions: Drug: Acetylsalicylic Acid (Asprin, BAYE4465);   Drug: Clopidogrel, Oral Anticoagulants, NSAIDs and SSRIs
33 Not yet recruiting Improving Quality of Care - Managing Atrial Fibrillation Through Care Teams and Health Information Technology
Condition: Atrial Fibrillation
Intervention: Other: Intervention
34 Not yet recruiting Anti-Thrombotic Strategy After Trans-Aortic Valve Implantation for Aortic Stenosis
Conditions: Symptomatic Aortic Stenosis;   Eligible for Transcatheter Aortic Valve Replacement
Interventions: Drug: Apixaban;   Drug: Standard of care
35 Recruiting Keep it SIMPLE: Improving Anti-Coagulation Medication Adherence
Conditions: Atrial Fibrillation;   Medication Adherence
Intervention: Other: Health Messaging (Non-Procedural)
36 Recruiting Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients
Condition: Unsuspected Pulmonary Embolism
Intervention: Drug: Heparin, fondaparinux, vitamin-K antagonists, aspirin
37 Recruiting Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events
Conditions: Venous Thromboembolism;   Deep Vein Thrombosis;   Pulmonary Embolism
Intervention:
38 Recruiting Register for New Oral Anticoagulants
Condition: Anticoagulation Treatment
Intervention:
39 Recruiting Sequential Expansion of Comparative Effectiveness of Anticoagulants
Condition: Atrial Fibrillation
Intervention:
40 Unknown  Evaluation of Pharmacokinetic and Pharmacodynamic Characteristics of Indobufen, an Anticoagulant Agent
Condition: Healthy
Intervention: Drug: Indobufen

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years